SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: chirodoc who wrote (2387)7/1/1998 10:47:00 PM
From: Profiteer  Respond to of 5402
 
Chirodoc: You get no argument from me buddy! I saw the light 2389 posts ago!! Ha ha



To: chirodoc who wrote (2387)7/2/1998 8:21:00 AM
From: Turboe  Read Replies (1) | Respond to of 5402
 
I hate that type of a return-- NOT ENOUGH!!



To: chirodoc who wrote (2387)7/2/1998 8:30:00 AM
From: Turboe  Read Replies (1) | Respond to of 5402
 
Business Summary
Northfield Laboratories (a development stage company) is engaged in the development of an alternative to transfused blood for use in the treatment of acute blood loss. For the nine months ended 2/28/98, the Company reported no revenues. Net loss increased 31% to $4.2 million. Results reflect increased R&D expenses related to the Phase III clinical trials. Results also reflect increased S/G/A costs due to higher travel and professional services expenses.
Statistics at a Glance -- NFLD Last Updated: June 26, 1998
Price and Volume
(updated June 26, 1998)
52-Week Low $8.00
Recent Price $15.00
52-Week High $17.25
Beta 0.85
Daily Volume (3-month avg) 94.9K
Share-Related Items
Market Capitalization $211.4M
Shares Outstanding 14.1M
Float 10.6M
Dividend Information
Annual Dividend none
Per-Share Data
Book Value (mrq) $4.05
Earnings (ttm) -$0.37
Sales N/A
Cash (mrq) $3.84
Valuation Ratios
Price/Book (mrq) 3.70
Price/Earnings N/A
Price/Sales N/A
Income Statements
Net Income (ttm) -$5.24M
Sales N/A
Profitability
Profit Margin N/A